Rosuvastatin

  • Watson's rosuvastatin zinc tablets receive tentative FDA approval

    Watson Pharmaceuticals Inc announced that its subsidiary, Watson Laboratories Inc, has received tentative approval from the United States Food and Drug Administration (FDA) for its rosuvastatin zinc 5, 10, 20 and 40 mg tablets. Watson's rosuvastatin …

    Rosuvastatin | 10 August 2011

  • China Pharma Holdings: SFDA Approval for Clinical Trials

    China Pharma Holdings has received official approval from China's State Food and Drug Administration (SFDA) to enter Phase I and Phase II clinical trials to test the efficacy of its cholesterol-lowering drug, Rosuvastatin. The company plans to be…

    Rosuvastatin | 29 June 2009

  • Cholesterol Drug Cuts Heart Risk

    Data from a study presented at the American Heart Association Scientific Sessions demonstrated that Crestor (rosuvastatin calcium) reduced major cardiovascular (CV) events by 44% compared to placebo. It also reduced the combined risk of cardiovascula…

    Rosuvastatin | 30 December 2008